Philogen S.p.A. Email Format
Pharmaceutical ManufacturingTuscany, Italy51-200 Employees
Philogen S.p.A. is a biopharmaceutical company focused on antibody-based therapies that target angiogenesis, the growth of new blood vessels implicated in cancer, rheumatoid arthritis, and age-related macular degeneration. Its work centers on isolating and developing lead antibody derivatives capable of selectively targeting the tumor vasculature in vivo, supported by a Zurich-based R&D unit (Philochem) and Siena-based GMP manufacturing in Siena, Tuscany. The company maintains partnerships with major pharmaceutical firms and holds an international patent portfolio, reflecting a collaborative approach and its position in the biotechnology and manufacturing landscape. Founded in 1996, Philogen operates within the pharmaceutical manufacturing and biotechnology sector from its Italian base. Recent developments include expansion of its Siena facilities and the granting of GMP certification for a new production site, with several antibody assets in clinical studies and two registrational studies planned.